Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Elevated endothelin-1 levels as risk factor for an impaired ocular blood flow measured by OCT-A in glaucoma

Claudia Lommatzsch*, Kai Rothaus, Lasse Schopmeyer, Maria Feldmann, Dirk Bauer, Swaantje Grisanti, Carsten Heinz, Maren Kasper

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

The purpose of this study was to ascertain whether a correlation exists between glaucoma-associated alteration of ocular vascular haemodynamics and endothelin-1 (ET-1) levels exist. Eyes of patients with cataract (n = 30) or glaucoma (n = 68) were examined with optical coherence tomography (OCT) and OCT-angiography (OCT-A; AngioVue™-RTVue-XR; Optovue, Fremont, California, USA). The peripapillary and the macular vessel density (VD) values were measured. Inferior and superior retinal nerve fibre layer (RNFL) thickness loss was used for further OCT staging. Aqueous humour of the examined eye and plasma were sampled during cataract or glaucoma surgery and analysed by means of ELISA to determine their ET-1 level. Glaucoma eyes are characterised by reductions in RNFL thickness and VD that correlate significantly with the OCT GSS score. Peripheral and ocular ET-1 level were significantly elevated in patients with glaucoma and correlate positively with the OCT-GSS score of the entire study population. Peripapillary and macula VD of glaucoma patients correlates negatively with plasma ET-1 levels. Multivariable analysis showed a subordinate role of intraocular pressure predictive factor for impaired retinal blood flow compared with plasma ET-1 level in glaucoma. Peripheral ET-1 level serves as risk factor for detection of ocular blood flow changes in the optic nerve head region of glaucomatous eyes.

OriginalspracheEnglisch
Aufsatznummer11801
ZeitschriftScientific Reports
Jahrgang12
Ausgabenummer1
ISSN2045-2322
DOIs
PublikationsstatusVeröffentlicht - 12.2022

Fördermittel

C.L. and M.K.: The study was supported by Novartis Pharma GmbH. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. We thank Dr. Paolo Brusini for his kind invitation to use the OCT staging tool in the current study (Brusini et al. 2018). We thank Dr. Jörg Koch, Dr. Suphi Taneri, and Prof. Dr. Arnd Heiligenhaus for patient recruitment.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Biomedizintechnik

DFG-Fachsystematik

  • 2.23-11 Augenheilkunde
  • 2.22-32 Medizinische Physik, Biomedizinische Technik

Fingerprint

Untersuchen Sie die Forschungsthemen von „Elevated endothelin-1 levels as risk factor for an impaired ocular blood flow measured by OCT-A in glaucoma“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren